Abstract shapes animated in a loop.
Dr Simon Barry
Meet Simon, a co-investigator on Rosetta
Simon Barry is a Executive Director at AstraZeneca, Cambridge UK. He has been involved in discovering and developing both small and large molecule therapeutics as well as nanoparticle therapeutics targeting both tumour cell and stromatolites pathways. His research focuses on the cross talk between the tumour and its micro environment, as well as elucidating drug mode of action and mechanisms underpinning therapeutic benefit.
AstraZeneca's Oncology group will support the Grand Challenge experimentally with specialist technical and scientific contributions, as well as with its portfolio of therapeutics, and help translate the findings to advance patient treatment options.